Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship
Open Access
- 1 January 2012
- journal article
- review article
- Published by Wiley in Advances in Urology
- Vol. 2012, 1-10
Abstract
Bladder cancer is the fifth most commonly diagnosed cancer and the most expensive adult cancer in average healthcare costs incurred per patient in the USA. However, little is known about factors influencing patients' treatment decisions, quality of life, and responses to treatment impairments. The main focus of this paper is to better understand the impact of muscle invasive bladder cancer on patient quality of life and its added implications for primary caregivers and healthcare providers. In this paper, we discuss treatment options, side effects, and challenges that patients and family caregivers face in different phases along the disease trajectory and further identify crucial areas of needed research.Keywords
Funding Information
- American Cancer Society (121193-MRSG-11-103-01-CPPB)
This publication has 66 references indexed in Scilit:
- Ileal Conduit as the Standard for Urinary Diversion After Radical Cystectomy for Bladder CancerEuropean Urology Supplements, 2010
- Renal and functional outcomes following cystectomy and neobladder reconstructionCanadian Urological Association Journal, 2010
- Orthotopic Neobladder versus Ileal Conduit Urinary Diversion after Cystectomy – A Quality-of-Life Based ComparisonThe Annals of The Royal College of Surgeons of England, 2009
- The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC studyBJU International, 2008
- Effect of Caregiver Perception of Preparedness on Burden in an Oncology PopulationOncology Nursing Forum, 2002
- Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segmentWorld Journal of Urology, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Illness cognition: Using common sense to understand treatment adherence and affect cognition interactionsCognitive Therapy and Research, 1992
- Psychosocial Sequelae of Ostomies in Cancer PatientsCA: A Cancer Journal for Clinicians, 1985